Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75,038 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial Preface for Targeted Cancer Therapy.
Chen G, Li W. Chen G, et al. Among authors: li w. Acta Pharm Sin B. 2018 Jul;8(4):501-502. doi: 10.1016/j.apsb.2018.07.003. Epub 2018 Jul 25. Acta Pharm Sin B. 2018. PMID: 30109174 Free PMC article. No abstract available.
Emerging roles of Aurora-A kinase in cancer therapy resistance.
Zheng D, Li J, Yan H, Zhang G, Li W, Chu E, Wei N. Zheng D, et al. Among authors: li j, li w. Acta Pharm Sin B. 2023 Jul;13(7):2826-2843. doi: 10.1016/j.apsb.2023.03.013. Epub 2023 Mar 15. Acta Pharm Sin B. 2023. PMID: 37521867 Free PMC article. Review.
Antibody-drug conjugates: Recent advances in payloads.
Wang Z, Li H, Gou L, Li W, Wang Y. Wang Z, et al. Among authors: li w, li h. Acta Pharm Sin B. 2023 Oct;13(10):4025-4059. doi: 10.1016/j.apsb.2023.06.015. Epub 2023 Jun 30. Acta Pharm Sin B. 2023. PMID: 37799390 Free PMC article. Review.
Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial.
Xu B, Zhang Q, Hu X, Li Q, Sun T, Li W, Ouyang Q, Wang J, Tong Z, Yan M, Li H, Zeng X, Shan C, Wang X, Yan X, Zhang J, Zhang Y, Wang J, Zhang L, Lin Y, Feng J, Chen Q, Huang J, Zhang L, Yang L, Tian Y, Shang H. Xu B, et al. Among authors: li w, li h, li q. Acta Pharm Sin B. 2023 May;13(5):2250-2258. doi: 10.1016/j.apsb.2023.02.001. Epub 2023 Feb 9. Acta Pharm Sin B. 2023. PMID: 37250148 Free PMC article. Clinical Trial.
75,038 results
You have reached the last available page of results. Please see the User Guide for more information.